首頁 > 市場調查報告書 > 醫療設備

子宮內避孕器（IUD）市場規模、佔有率及成長分析（按類型和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1904768

子宮內避孕器（IUD）市場規模、佔有率及成長分析（按類型和地區分類）－2026-2033年產業預測

Intrauterine Devices Market Size, Share, and Growth Analysis, By Type (Nonhormonal: Copper-containing IUD, Hormonal: Progestogen-releasing25-34 years), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，子宮內避孕器 (IUD) 市場規模將達到 33.6 億美元，到 2025 年將達到 34.9 億美元，到 2033 年將達到 47 億美元，預測期（2026-2033 年）的複合年成長率為 3.8%。

子宮內避孕器（IUD）市場正經歷顯著成長，這主要得益於多種因素，包括意外懷孕和不安全墮胎的增加，以及人們對這些避孕方法的認知度不斷提高。政府的扶持政策和主要企業對先進設備研發的投入，都在推動市場需求。尤其是在美國，計劃性延遲生育的趨勢，使得人們更容易獲得生殖健康服務。然而，子宮內避孕器使用認知度低、潛在的副作用（如疼痛和不規則出血）以及過早取出等問題，都對市場擴張構成了阻礙。同時，新興經濟體可支配收入的增加和人們對健康生活方式日益成長的關注，也為市場創造了機會。有利的法規環境和持續的技術創新有望進一步鞏固市場格局。

子宮內避孕器市場促進因素

人們對計劃生育的認知不斷提高，對可靠避孕方法的需求日益成長，這極大地推動了子宮內避孕器市場的成長。隨著越來越多的人和醫療專業人員認知到長期避孕方案的益處，子宮內避孕器的普及率和需求量也隨之飆升。這種意識的轉變凸顯了有效生殖健康選擇的重要性，從而促進了子宮內避孕器的廣泛接受和使用。因此，在各方共同致力於幫助個人就其生殖健康和計劃生育策略做出知情選擇的推動下，子宮內避孕器市場正經歷強勁成長。

限制子宮內避孕器市場的因素

由於子宮內避孕器市場受到嚴格的監管架構限制，因此面臨許多限制因素。對於製造商而言，確保產品符合安全性和有效性標準是一項複雜的挑戰，通常需要大量的文件工作和核准流程。這種監管負擔不僅給現有企業帶來挑戰，也阻礙了新進入者在市場中立足。因此，這些嚴格的要求可能會抑制市場整體成長，並阻礙潛在競爭對手在子宮內避孕器領域尋求商機。

子宮內避孕器市場趨勢

受意外懷孕率上升和生殖健康意識增強的推動，子宮內避孕器（IUD）市場呈現顯著成長趨勢。尤其是含激素子宮內避孕器，因其既能有效避孕又能緩解月經症狀（如經痛和月經月經）的雙重益處而備受關注。衛生組織為推廣計劃生育和提高公眾對各種避孕方法益處的認知所做的努力，也進一步促進了市場成長。此外，子宮內避孕器安全性高，能最大程度降低子宮外孕和生殖健康問題的風險，因此在未生育女性和青少年女性中越來越受歡迎，這也反映了這一趨勢。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

AbbVie Inc.
Bayer AG
CooperSurgical Inc.
DKT International
EUROGINE, SL
Mona Lisa NV
OCON Medical Ltd.
Pregna International Limited.
Prosan International BV
SMB Corporation of India
Teva Pharmaceuticals
ANI Pharmaceuticals
Mylan NV（Viatris）
Melbea AG
Contrel Europe
Durbin
Gima SpA
HLL Lifecare Limited
Meril Life Sciences Pvt. Ltd
Mona Lisa NV

結論與建議

簡介目錄

Product Code: SQMIG35A2678

Intrauterine Devices Market size was valued at USD 3.36 Billion in 2024 and is poised to grow from USD 3.49 Billion in 2025 to USD 4.7 Billion by 2033, growing at a CAGR of 3.8% during the forecast period (2026-2033).

The intrauterine devices (IUD) market is experiencing significant growth due to various driving factors, including the rising incidence of unplanned pregnancies and unsafe abortions, along with heightened awareness of these contraceptive options. Demand is bolstered by government initiatives and key players investing in research to develop advanced devices. The trend of planned delayed pregnancies, especially in the U.S., is facilitating access to reproductive health services. However, challenges such as limited awareness regarding IUD use, potential side effects like pain and irregular bleeding, and premature removal hinder market expansion. In contrast, increasing disposable incomes and a growing focus on healthy lifestyles in emerging economies present opportunities. Favorable regulations and ongoing technological advancements are anticipated to further enhance the market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Intrauterine Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Intrauterine Devices Market Segments Analysis

Global Intrauterine Devices Market is segmented by Type, by Age Group, by Distribution Channel, by End User and by Region. Based on Type, the market is segmented into Nonhormonal: Copper-containing IUD, Hormonal: Progestogen-releasing. Based on Age Group, the market is segmented into 25-34 years, 35-44 years, Above 44 years, 15-24 years. Based on Distribution Channel, the market is segmented into Hospital, Gynecology Clinics, Community Health Care Centers, and Others. Based on End User, the market is segmented into Hospitals, Clinics, Community Health Care Centres, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Driver of the Intrauterine Devices Market

The rising awareness surrounding family planning and the necessity for reliable contraception methods has significantly fueled the growth of the intrauterine devices market. As more individuals and healthcare professionals acknowledge the advantages of long-lasting birth control solutions, the popularity and demand for IUDs have surged. This shift in perception emphasizes the importance of effective reproductive health options, leading to greater acceptance and utilization of intrauterine devices. Consequently, the market is experiencing robust growth, driven by the collective focus on empowering individuals to make informed choices about their reproductive health and family planning strategies.

Restraints in the Intrauterine Devices Market

The market for intrauterine devices faces significant constraints due to the rigorous regulatory frameworks governing these medical products. Ensuring compliance with safety and efficacy standards can prove to be a complex task for manufacturers, often requiring extensive documentation and approval processes. This regulatory burden not only poses challenges for existing players but also serves as a barrier to new entrants seeking to establish themselves in the market. Consequently, these stringent requirements can impede overall market growth, as potential competitors may be deterred from pursuing opportunities in the intrauterine device sector.

Market Trends of the Intrauterine Devices Market

The Intrauterine Devices (IUDs) market is experiencing a notable upward trend driven by the rising incidence of unplanned pregnancies and an increasing awareness of reproductive health. Hormonal IUDs are particularly gaining traction for their dual benefits of effective contraception and management of menstrual symptoms, including severe cramps and heavy bleeding. Initiatives by health organizations to promote family planning and educate the public on the advantages of various contraceptive methods further enhance market growth. This trend is also reflected in the growing acceptance of IUDs among nulliparous women and adolescents, thanks to their safety profile, which minimizes risks associated with ectopic pregnancies and reproductive health issues.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies

Global Intrauterine Devices Market Size by Type & CAGR (2026-2033)

Nonhormonal: Copper-containing IUD
Hormonal: Progestogen-releasing IUD

Global Intrauterine Devices Market Size by Age Group & CAGR (2026-2033)

25-34 years
35-44 years
Above 44 years
15-24 years

Global Intrauterine Devices Market Size by Distribution Channel & CAGR (2026-2033)

Hospital
Gynecology Clinics
Community Health Care Centers
Others

Global Intrauterine Devices Market Size by End User & CAGR (2026-2033)

Hospitals
Clinics
Community Health Care Centres
Others

Global Intrauterine Devices Market Size by Region & CAGR (2026-2033)

North America, (by Type, by Age Group, by Distribution Channel, by End User)
- US
- Canada
Europe, (by Type, by Age Group, by Distribution Channel, by End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (by Type, by Age Group, by Distribution Channel, by End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (by Type, by Age Group, by Distribution Channel, by End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (by Type, by Age Group, by Distribution Channel, by End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DKT International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EUROGINE, S.L.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mona Lisa N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OCON Medical Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pregna International Limited.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prosan International BV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMB Corporation of India
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teva Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ANI Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mylan NV (Viatris)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Melbea AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Contrel Europe
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Durbin
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gima S.p.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HLL Lifecare Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meril Life Sciences Pvt. Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mona Lisa N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments